A novel CRTH2 antagonist: Single‐ and multiple‐dose tolerability, pharmacokinetics, and pharmacodynamics of ACT‐453859 in healthy subjects

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 7, 2015-07 ,pp. : 787-797

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effect of rifampin on the pharmacokinetics and pharmacodynamics of prasugrel in healthy male subjects

By Farid N. A.   Jakubowski J. A.   Payne C. D.   Li Y. G.   Jin Y.   Ernest C. S.   Winters K. J.   Brandt J. T.   Salazar D. E.   Small D. S.  

Current Medical Research and Opinion, Vol. 25, Iss. 8, 2009-08 ,pp. : 1821-1829

Informa Healthcare

Access to resources Recommend Favorite

Pharmacodynamics and Pharmacokinetics of Fluticasone Furoate/Vilanterol in Healthy Chinese Subjects

By  

PHARMACOTHERAPY: THE JOURNAL OF HUMAN PHARMACOLOGY AND DRUG THERAPY, Vol. 35, Iss. 6, 2015-06 ,pp. : 586-599

John Wiley & Sons Inc

Access to resources Recommend Favorite

Easy-to-implement Bayesian methods for dose-escalation studies in healthy volunteers

By Whitehead J.  

Biostatistics, Vol. 2, Iss. 1, 2001-03 ,pp. : 47-61

Oxford University Press

Access to resources Recommend Favorite

Switching from rivaroxaban to warfarin: an open label pharmacodynamic study in healthy subjects

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 79, Iss. 6, 2015-06 ,pp. : 907-917

John Wiley & Sons Inc

Access to resources Recommend Favorite